Showing results 1 to 20 of 101
next >
| Issue Date | Title | Author(s) |
| 2023-09 | Estimating the time of human decomposition based on skeletal muscle biopsy samples utilizing an untargeted LC-MS/MS-based proteomics approach. | Brockbals, L; Garrett-Rickman, S; Fu, S; Ueland, M; McNevin, D; Padula, MP |
| 2023-04-01 | 3-Methoxytyrosine as an indicator of dopaminergic manipulation in equine plasma. | Keen, B; Cawley, A; Reedy, B; Noble, G; Loy, J; Fu, S |
| 2023-04 | HPLC-MS/MS determination and the postmortem distribution or postmortem redistribution of paraquat and its metabolites in four fatal intoxication cases. | Ma, H; Hu, M; Zhang, C; Jia, J; Fu, S; Wei, Z; Yun, K |
| 2023-03 | Field-dependent deep learning enables high-throughput whole-cell 3D super-resolution imaging. | Fu, S; Shi, W; Luo, T; He, Y; Zhou, L; Yang, J; Yang, Z; Liu, J; Liu, X; Guo, Z; Yang, C; Liu, C; Huang, Z-L; Ries, J; Zhang, M; Xi, P; Jin, D; Li, Y |
| 2023-03 | Simulating dynamic interaction between diazepam and ethanol targeting the GABAA receptor via in silico model. | Wang, L; Wang, R; Zheng, Q; Yao, X; Zhang, C; Fu, S; Wei, Z; Yun, K; Guo, Z |
| 2023-01-01 | New Psychoactive Substances | Alonzo, M; Fu, S; Houck, MM |
| 2023-01-01 | Hallucinogens | Alonzo, M; Fu, S; Houck, MM |
| 2023-01-01 | Cocaine | Alonzo, M; Fu, S; Houck, MM |
| 2022-12-30 | Towards Non-Targeted Screening of Lipid Biomarkers for Improved Equine Anti-Doping. | Tou, K; Cawley, A; Bowen, C; Bishop, DP; Fu, S |
| 2022-11 | Portable testing techniques for the analysis of drug materials | Alonzo, M; Alder, R; Clancy, L; Fu, S |
| 2022-10-01 | Rat-modelled Distribution of Methcathinone and Its Metabolites | Yang, X; Wang, X; He, Q; Yu, W; Wang, L; Zhang, C; Wang, T; Fu, S; Yun, K; Wei, Z |
| 2022-09 | Complementary biomarker detection for bisphosphonate use in racehorses | Tou, K; Cawley, A; Bishop, D; Bowen, C; Noble, G; Fu, S |
| 2022-09 | A statistical focus on doping using a metabolomics approach | Keen, B; Cawley, A; Reedy, B; Noble, G; Fu, S |
| 2022-09 | Metabolomic analysis of equine urine to determine route of altrenogest administration | Elbourne, M; Fu, S; Cawley, A; Bowen, C; Gupta, A |
| 2022-07-01 | Comparison between human liver microsomes and the fungus Cunninghamella elegans for biotransformation of the synthetic cannabinoid JWH-424 having a bromo-naphthyl moiety analysed by high-resolution mass spectrometry | Watanabe, S; Iwai, T; Matsushita, R; Nakanishi, T; Kuzhiumparambil, U; Fu, S; Seto, Y |
| 2022-05 | Metabolomics in clinical and forensic toxicology, sports anti-doping and veterinary residues. | Keen, B; Cawley, A; Reedy, B; Fu, S |
| 2022-05 | Intelligence benefit of the 3-methoxytyramine to tyramine ratio in equine urine. | Elbourne, M; Cawley, A; Stanley, S; Bowen, C; Fu, S |
| 2022-05 | Measurements of hydrocortisone and cortisone for longitudinal profiling of equine plasma by liquid chromatography-tandem mass spectrometry. | Tou, K; Cawley, A; Bowen, C; Sornalingam, K; Fu, S |
| 2022-04 | Developments in high-resolution mass spectrometric analyses of new psychoactive substances. | Klingberg, J; Keen, B; Cawley, A; Pasin, D; Fu, S |
| 2022-02-01 | Liquid Chromatography-triple Quadrupole Mass Spectrometry Simultaneously Detecting Paraquat and Metabolites in Biological Samples | Meng, Y; Gong, D; Li, W; Wen, Y; Fan, Z; Zhang, C; Wang, T; Fu, S; Wei, Z; Yun, K |
